A comprehensive review and meta-analysis of risk factors for statin-induced myopathy

Khoa A. Nguyen, Lang Li, Deshun Lu, Aida Yazdanparast, Lei Wang, Rolf P. Kreutz, Elizabeth C. Whipple, Titus K. Schleyer

Research output: Contribution to journalReview article

8 Scopus citations


Purpose: To aid prescribers in assessing a patient’s risk for statin-induced myopathy (SIM), we performed a comprehensive review of currently known risk factors and calculated aggregated odds ratios for each risk factor through a meta-analysis. Methods: This meta-analysis was done through four phases: (1) Identification of the relevant primary literature; (2) abstract screening using inclusion and exclusion criteria; (3) detailed review and data extraction; and (4) synthesis and statistical analysis. Results: Out of 44 papers analyzed from 836 papers searched from MEDLINE, 18 different potential risk factors were collected, divided into three categories: three demographics (11 papers), ten clinical factors (31 papers), and five pharmacogenetics/biomarkers (12 papers). Risk factors significant for myopathy and/or rhabdomyolysis included age, gender, diabetes, renal impairment, cardiovascular disease, certain interacting drugs, and mutations of the SLCO1B1 gene, which encodes a transporter protein in the liver. Several factors, such as gender, race, cardiovascular disease, and the GATM gene, which encodes a protein for creatine synthesis, appeared to be protective in terms of the outcomes of interest. Conclusions: This comprehensive assessment of risk factors can help support clinicians in reducing the incidence of SIM in their patient population on statins.

Original languageEnglish (US)
Pages (from-to)1099-1109
Number of pages11
JournalEuropean Journal of Clinical Pharmacology
Issue number9
StatePublished - Sep 1 2018


  • Comprehensive review
  • Myotoxicity
  • Risk factors
  • Risks
  • Statin-induced myopathy
  • Statins

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'A comprehensive review and meta-analysis of risk factors for statin-induced myopathy'. Together they form a unique fingerprint.

  • Cite this